{
  "main_header": {
    "sid": 250971,
    "name": "Relaxo Footwear",
    "stock_name": "Relaxo Footwear",
    "full_name": "Relaxo Footwears Ltd",
    "name_url": "stocks-analysis/relaxo-footwear",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "378.85",
    "chg": -2.55,
    "chgp": "-0.67%",
    "dir": -1,
    "prev_price": "381.40",
    "mcapval": "9,592.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 530517,
    "symbol": "RELAXO",
    "ind_name": "Footwear",
    "ind_code": 14,
    "indexname": "",
    "isin": "INE131B01039",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.48 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/relaxo-footwear-250971-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "250971",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/relaxo-footwears-250971"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "31-Jan-2026",
      "details": "Newspaper Publication of Unaudited Financial Results of the Company for the Quarter and Nine months ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of Board Meeting For Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025",
      "datetime": "30-Jan-2026",
      "details": "Outcome of Board Meeting for approval of Unaudited Financial Results for the Quarter and Nine Months ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "30-Jan-2026",
      "details": "Investor Presentation on Unaudited Financial Results of the Company for the Quarter and Nine months ended on December 31 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Relaxo Footwears Ltd has declared <strong>300%</strong> dividend, ex-date: 21 Aug 25",
          "dt": "2025-08-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Relaxo Footwears Ltd has announced <strong>1:5</strong> stock split, ex-date: 22 Nov 13",
          "dt": "2013-11-22",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Relaxo Footwears Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 26 Jun 19",
          "dt": "2019-06-26",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News